| PROTAC | Proteolysis-Targeting Chimera |
| TPD | Targeted protein degradation |
| AD | Alzheimer’s disease |
| PD | Parkinson’s disease |
| POI | Protein of interest |
| VHL | von Hippel–Lindau |
| CRBN | Cereblon |
| bRo5 | Beyond Rule-of-Five |
| GSK-3 | Glycogen synthase kinase 3 |
| PROTAC | Proteolysis-Targeting Chimera |
| TPD | Targeted protein degradation |
| AD | Alzheimer’s disease |
| PD | Parkinson’s disease |
| POI | Protein of interest |
| VHL | von Hippel–Lindau |
| CRBN | Cereblon |
| bRo5 | Beyond Rule-of-Five |
| GSK-3 | Glycogen synthase kinase 3 |